Foley & Lardner LLP represented TCGX as co-lead investor. Alkeus Pharmaceuticals closed its $150 million Series B financing for Alkeus Pharmaceuticals. TCGX was joined by Bain…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
